Skip to content

The Effect of Yoga Practice on Pain Intensity, Menstruation Symptoms and Quality of Life in Primary Dysmenorrhea

The Effect of Yoga Practice on Pain Intensity, Menstruation Symptoms and Quality of Life in Nursing Students With Primary Dysmenorrhea

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04910529
Enrollment
60
Registered
2021-06-02
Start date
2021-05-20
Completion date
2022-02-20
Last updated
2022-11-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain, Menstrual, Primary Dysmenorrhea, Quality of Life

Keywords

yoga, menstrual pain, menstrual symptoms, quality of life, nursing students, primary dysmenorrhea

Brief summary

The aim of this randomized controlled study is to evaluate the effect of yoga practice on pain intensity, menstruation symptoms and quality of life in nursing students with primary dysmenorrhea. The hypothesis of this study is that yoga reduces pain and menstrual symptom severity and improves quality of life.

Detailed description

In the study, 52 students will be randomly assigned to intervention (yoga) and control groups. The researcher will provide information about the purpose of the study and the study process by interviewing all the students in the sample online. All students participating in the study, who are in the yoga or control group of the study, will be given a data collection form as a pre-test by the researcher. Hatha yoga will be applied to the students (n = 26) in the yoga group in the study. Considering the studies conducted with these students, it is planned to practice Hatha yoga for 60 minutes twice a week for three menstrual cycles (12 weeks). Yoga practice will be done online by the researcher Aslıhan Aksu (A.A.), who has a Yoga Alliance-approved yoga instructor certificate, on the determined days and times using appropriate platforms. In the control group (n=26), no intervention will be made for 12 weeks. The results will be collected through data collection forms before the yoga practice and after the 12-week yoga practice is completed. The data collection forms applied to all students in the yoga and control groups at the beginning of the study will be applied to the control group again at the end of 12 weeks. The primary expected result of the study is the effect of yoga on students' menstrual pain intensity. The secondary expected results of the study are to determine the effect of yoga on students' menstrual symptoms and quality of life.

Interventions

OTHERYoga

Hatha yoga, which is one of the most basic yoga methods, will be applied to the students in the study. During each practice within the scope of Hatha yoga, students; breathing exercises, relaxation techniques and warm-up exercises will be applied respectively. In addition to these, asanas (yoga postures) with balance, stretching, relaxation and strengthening components will be applied to the students.

Sponsors

Mersin University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Outcomes Assessor)

Masking description

Participants and the researcher who carried out the application Aslıhan Aksu (A.A.) cannot be blinded due to the nature of the study. When the study is completed, the control and experimental groups will be coded as A and B and the data will be transferred to the computer environment by an independent researcher. The data coded as A and B will be analyzed by a statistician and the findings will be reported.

Intervention model description

Prospective, parallel, two arm, randomized controlled clinical trial

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 24 Years
Healthy volunteers
Yes

Inclusion criteria

* Accepting voluntarily to participate in the study. * Studying in 1st and 2nd grade between 18 October 2021-16 September 2022 at Mersin University Faculty of Nursing in the Academic Year of 2021-2022, * Between the ages of 18-24 years, * Willing to participate in the study, * Having the facilities (computer, internet, etc.) to participate in the online training, * Having female gender and a regular menstruation period (occurring at intervals of 21-35 days and lasting 3-8 days), * Having menstrual pain intensity at least 4 points according to the Visual Pain Scale, * Having a score of 60 or more according to the Menstruation Symptom Scale, * Not using hormonal contraception and intrauterine equipment, * Not pregnant and have not experienced pregnancy before, * Not having a systemic and chronic disease, * There is no physical health problem that will prevent/limit yoga practice, * No diagnosed musculoskeletal disease or no severe heart disease, * Not practicing yoga regularly, * No diagnosed psychiatric problems, * Did not take the Obstetrics-Women's Health and Diseases Nursing course, * Female students with primary dysmenorrhea who signed the Informed Consent Form.

Exclusion criteria

* Not accepting voluntarily to participate in the study. * Studying in Mersin University Nursing Faculty in the 1st and 2nd grade except 18 October 2021-16 September 2022 in the Academic Year of 2021-2022, * Younger than 18 years old or over 24 years old, * Not having the facilities (computer, internet, etc.) to participate in the online training, * Not having female gender and a regular menstruation period, * Menstrual pain intensity less than 4 points according to the Visual Pain Scale, * Having a score of 59 or less according to the Menstruation Symptom Scale, * Using hormonal contraception and intrauterine device, * Pregnant and have experienced pregnancy before, * Having a systemic and chronic disease, * Having a physical health problem that will prevent/limit yoga practice, * Diagnosed musculoskeletal disease or severe heart disease, * Doing regular yoga exercises, * Having a psychiatric problem, * Obstetrics-Gynecology and Diseases Nursing course, * Students without primary dysmenorrhea who do not sign the Informed Consent Form.

Design outcomes

Primary

MeasureTime frameDescription
Pain will evaluate using The The Short Form of the McGill Pain QuestionnaireChange from before implementation and 12th week of practiceThe main component of the The Short Form of the McGill Pain Questionnaire (SF-MPQ) consists of 15 descriptors (11 sensory; 4 affective) which are rated on an intensity scale as 0=none, 1=mild, 2=moderate or 3=severe. In this section, sensory (0-33 points), affective (0-12 points) and total (0-45 points) pain quality scores are obtained. The increase in the total pain scores indicates an increase in the perception of pain. The SF-MPQ also includes the Present Pain Intensity (PPI) Index of the Standard MPQ and a Visual Analogue Scale (VAS).

Secondary

MeasureTime frameDescription
Menstrual symptoms will evaluate using the Menstrual Symptom QuestionnaireChange from before implementation and 12th week of practice.Menstruation Symptom Scale was developed to evaluate menstrual pain and symptoms. Participants in the scale give a value between 1 and 5 (1 = never, 2 = sometimes, 3 = occasionally, 4 = often, 5 = always) to symptoms they experience about menstruation. Scores ranging from 20 to 80 points are obtained in the scale. Increasing the average score indicates that the severity of menstrual symptoms increased.
Quality of life will evaluate using SF-36 Quality of Life QuestionnaireChange from before implementation and 12th week of practiceSF-36 Quality of Life Questionnaire covers many concepts related to general health and is used frequently today. SF-36 consists of 8 sub-dimensions (physical function, physical role restriction, emotional role restriction, bodily pain, general health perception, energy / vitality, social function, mental health) and 36 questions in total. In the scale, eight sub-dimensions can be evaluated separately as well as in two main dimensions, physical and mental dimensions. Subscales evaluate health between 0 and 100 points (0 point = bad health, 100 points = good health).

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026